Blog
Outsourced manufacturing: A strategic advantage for the healthcare industry
In May 2024, Tosoh Bioscience selected Flex as its manufacturing partner for Automated Glycohemoglobin Analyzers at our site in Suzhou, China. This device plays a crucial role in diabetes management and diagnosis, as well as beta-thalassemia screening worldwide.
Tosoh Corporation and Flex came together on Wednesday June 12, 2024, to officiate our partnership in an MSA signing ceremony.
Flex is committed to creating business value across the healthcare product lifecycle, from design to end-of-life, to improve healthcare solutions for patients and practitioners.
We are confident that our in-depth and proven experience in manufacturing large scale medical equipment coupled with strong experience in China’s Market Authorization Holder policy will help Tosoh speed up time to market.
— Steven Yang, General Manager, Flex Suzhou site
This collaboration reflects Flex’s commitment to delivering value and expertise in highly regulated industries like healthcare, where we can help our customers deliver products to global markets faster and at scale with the shared goal of improving lives.
